Drug intelligence / Profile preview

PBAE 456

Development stage
Preclinical
Lead developer
Johns Hopkins University
Modality
Gene Therapies, Nanoparticles → Drug Delivery Systems
Administration
Intratumoral, Intravenous
01

Overview

PBAE 456 is a specific cationic, biodegradable poly(β-amino ester) (PBAE) polymer developed for non-viral gene delivery. Identified through a high-throughput screen of a PBAE library at Johns Hopkins University, PBAE 456 demonstrated superior transfection efficiency in small cell lung cancer (SCLC) cell lines. The polymer self-assembles with plasmid DNA to form nanoparticles that protect the genetic cargo and facilitate its intracellular delivery via endocytosis and subsequent endosomal escape. In preclinical studies, PBAE 456 has been used to deliver wild-type p53 (TP53) to p53-mutant SCLC cells, resulting in p21 induction, cell cycle arrest, and anti-proliferative effects. It has shown potential for both local (intratumoral) and systemic (intravenous) administration in SCLC xenograft models.

Other names
poly(beta-amino ester) 456
02

Targets

ASEP (Anionic serum and extracellular proteins)

Beyond the preview

Go deeper on PBAE 456.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PBAE 456.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call